Tsx Inhibitors
Tsx inhibitors are a class of chemical compounds designed to target and inhibit the Tsx protein, which is a bacterial nucleoside channel located in the outer membrane of Escherichia coli (E. coli) and other Gram-negative bacteria. The Tsx protein functions as a pore-forming channel that facilitates the uptake of nucleosides, which are essential components for bacterial metabolism and nucleic acid synthesis. Tsx also serves as a receptor for certain bacteriophages. By inhibiting the activity of the Tsx protein, these compounds block the uptake of nucleosides, disrupting the bacteria's ability to access critical resources for growth and replication. Tsx inhibitors interfere with the channel's ability to transport molecules across the bacterial outer membrane, thus impacting the metabolic processes dependent on nucleoside uptake.
Chemically, Tsx inhibitors are designed to specifically bind to the Tsx channel and block its pore, preventing nucleosides from passing through. These inhibitors may mimic the structure of natural nucleosides, competing for binding within the channel and obstructing its function. The structural design of Tsx inhibitors often focuses on high specificity for the Tsx protein to avoid off-target effects on other bacterial transport systems. Researchers develop these compounds by studying the three-dimensional structure of the Tsx protein, identifying key regions within the pore that can be targeted for inhibition. The study of Tsx inhibitors provides insights into bacterial outer membrane transport mechanisms and helps in understanding how bacteria regulate the uptake of essential nutrients. This research also sheds light on the broader principles of channel protein function and regulation in prokaryotic organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Flutamide | 13311-84-7 | sc-204757 sc-204757A sc-204757D sc-204757B sc-204757C | 1 g 5 g 25 g 500 g 1 kg | $47.00 $156.00 $171.00 $525.00 $941.00 | 4 | |
Flutamide inhibits the expression of the testis-specific X-linked gene by acting as an androgen receptor antagonist, thereby blocking androgen signaling pathways that regulate the transcription of genes associated with male reproductive functions. | ||||||
MDV3100 | 915087-33-1 | sc-364354 sc-364354A | 5 mg 50 mg | $245.00 $1051.00 | 7 | |
Enzalutamide inhibits the expression of the testis-specific X-linked gene by competitively binding to the androgen receptor, preventing its activation and downstream transcriptional activity, which includes the regulation of genes involved in male reproductive processes. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
Bicalutamide inhibits the expression of the testis-specific X-linked gene by antagonizing the androgen receptor, leading to the suppression of androgen-dependent transcriptional processes involved in male reproductive function, including the expression of this gene. | ||||||
Abiraterone Acetate | 154229-18-2 | sc-207240 | 5 mg | $231.00 | 1 | |
Abiraterone acetate inhibits the expression of the testis-specific X-linked gene by blocking the activity of CYP17A1, an enzyme involved in androgen biosynthesis, resulting in decreased androgen levels and subsequent downregulation of androgen-dependent gene expression. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole inhibits the expression of the testis-specific X-linked gene by inhibiting CYP17A1, a key enzyme in androgen biosynthesis, leading to decreased levels of androgens and consequent downregulation of androgen-dependent gene transcription, including this gene. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
Finasteride inhibits the expression of the testis-specific X-linked gene by inhibiting 5α-reductase, an enzyme involved in the conversion of testosterone to dihydrotestosterone (DHT), resulting in reduced levels of DHT, which is a potent activator of androgen receptor-mediated gene expression. | ||||||
Dutasteride | 164656-23-9 | sc-207600 | 10 mg | $167.00 | 2 | |
Dutasteride inhibits the expression of the testis-specific X-linked gene by blocking both isoforms of 5α-reductase, thereby reducing the conversion of testosterone to dihydrotestosterone (DHT), leading to decreased androgen signaling and downregulation of androgen-responsive genes. | ||||||
Cyproterone Acetate | 427-51-0 | sc-204703 sc-204703A | 100 mg 250 mg | $60.00 $199.00 | 5 | |
Cyproterone acetate inhibits the expression of the testis-specific X-linked gene by acting as a potent antagonist of the androgen receptor and by exerting progestogenic activity, which collectively suppress androgen-dependent gene transcription, including this gene. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone inhibits the expression of the testis-specific X-linked gene by acting as an antagonist of the mineralocorticoid receptor and exerting anti-androgenic effects, resulting in reduced androgen signaling and downregulation of androgen-responsive gene expression, including this gene. | ||||||
Apalutamide | 956104-40-8 | sc-507442 | 5 mg | $290.00 | ||
Apalutamide inhibits the expression of the testis-specific X-linked gene by competitively binding to the androgen receptor and preventing its activation by androgens, leading to suppression of androgen-mediated transcriptional processes, including the expression of this gene. | ||||||